Both medications work. The right one for you depends on your biology, your goals, and your tolerance, not on marketing. Here is the physician-level view.
Medically reviewed by Gurdarshan Sandhu, MD . Reviewed August 2026
Figures reflect published clinical research; individual results vary more than averages suggest.
Short, honest answers. The long version happens with your clinician, using your labs.
In head to head research, tirzepatide produced greater average weight loss. But averages hide individuals: plenty of people respond better to semaglutide, tolerate it better, or reach their goal on either. Your response is discovered, not predicted.
Your AlyneMD program fee is identical for both. Medication cost depends on your pharmacy benefits and manufacturer savings programs, which our coverage check estimates before you commit to anything.
Yes, and patients do, in both directions, guided by response and tolerability. Switching is a clinical decision your clinician manages, not a new enrollment.
Oral GLP-1 medication is the newest entrant and availability is expanding now. If needles are the obstacle, raise it at your visit.
The full page: how it works, the honest safety section, pricing, and the timeline to your first dose.
Read the semaglutide pageThe full page: mechanism, trial results, safety considerations, and program pricing.
Read the tirzepatide pageThe comparison that matters is between these medications and your biology. Start the evaluation and decide with a clinician.
Assess your candidacy908-888-9199 . ALYNEMD.COM
Assess your candidacy